Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Wiley

Showing results (591-600 of 619) with videos related to

Pageof 62
Sort By:
European Journal of Pharmacology|August 29, 2017
Tobacco's minor alkaloids: Effects on place conditioning and nucleus accumbens dopamine release in adult and adolescent ratsJulie A Marusich, Mahesh Darna, A George Wilson, et al.
Head & Neck|March 20, 2023
Dual Axl/MerTK inhibitor INCB081776 creates a proinflammatory tumor immune microenvironment and enhances anti-PDL1 efficacy in head and neck cancerKourtney L Kostecki, Mari Iida, Anne L Wiley, et al.
Annals of Internal Medicine|June 16, 2004
Medical management of the acute radiation syndrome: recommendations of the Strategic National Stockpile Radiation Working GroupJamie K Waselenko, Thomas J MacVittie, William F Blakely, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 8, 2006
Pharmacological characterization of novel water-soluble cannabinoidsBilly R Martin, Jenny L Wiley, Irina Beletskaya, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 15, 2017
Thermolytic Degradation of Synthetic Cannabinoids: Chemical Exposures and Pharmacological ConsequencesBrian F Thomas, Timothy W Lefever, Ricardo A Cortes, et al.
British Journal of Pharmacology|July 16, 2013
In vivo characterization of the highly selective monoacylglycerol lipase inhibitor KML29: antinociceptive activity without cannabimimetic side effectsB M Ignatowska-Jankowska, S Ghosh, M S Crowe, et al.
Psychopharmacology|April 1, 2010
Kappa opioid mediation of cannabinoid effects of the potent hallucinogen, salvinorin A, in rodentsD Matthew Walentiny, Robert E Vann, Jonathan A Warner, et al.
Annals of the New York Academy of Sciences|September 29, 2011
Barrett's esophagus: prevalence and incidence of adenocarcinomasHelen M Shields, Gerardo Nardone, Jingjing Zhao, et al.
The Journal of Thoracic and Cardiovascular Surgery|June 26, 2016
Pathway for surgeons and programs to establish and maintain a successful robot-assisted adult cardiac surgery programEvelio Rodriguez, L Wiley Nifong, Johannes Bonatti, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 16, 2014
Δ9-tetrahydrocannabinol and endocannabinoid degradative enzyme inhibitors attenuate intracranial self-stimulation in miceJason M Wiebelhaus, Travis W Grim, Robert A Owens, et al.
Pageof 62

Showing results (591-600 of 619) with videos related to

Sort By:
Pageof 62
European Journal of Pharmacology|August 29, 2017
Tobacco's minor alkaloids: Effects on place conditioning and nucleus accumbens dopamine release in adult and adolescent ratsJulie A Marusich, Mahesh Darna, A George Wilson, et al.
Head & Neck|March 20, 2023
Dual Axl/MerTK inhibitor INCB081776 creates a proinflammatory tumor immune microenvironment and enhances anti-PDL1 efficacy in head and neck cancerKourtney L Kostecki, Mari Iida, Anne L Wiley, et al.
Annals of Internal Medicine|June 16, 2004
Medical management of the acute radiation syndrome: recommendations of the Strategic National Stockpile Radiation Working GroupJamie K Waselenko, Thomas J MacVittie, William F Blakely, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 8, 2006
Pharmacological characterization of novel water-soluble cannabinoidsBilly R Martin, Jenny L Wiley, Irina Beletskaya, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 15, 2017
Thermolytic Degradation of Synthetic Cannabinoids: Chemical Exposures and Pharmacological ConsequencesBrian F Thomas, Timothy W Lefever, Ricardo A Cortes, et al.
British Journal of Pharmacology|July 16, 2013
In vivo characterization of the highly selective monoacylglycerol lipase inhibitor KML29: antinociceptive activity without cannabimimetic side effectsB M Ignatowska-Jankowska, S Ghosh, M S Crowe, et al.
Psychopharmacology|April 1, 2010
Kappa opioid mediation of cannabinoid effects of the potent hallucinogen, salvinorin A, in rodentsD Matthew Walentiny, Robert E Vann, Jonathan A Warner, et al.
Annals of the New York Academy of Sciences|September 29, 2011
Barrett's esophagus: prevalence and incidence of adenocarcinomasHelen M Shields, Gerardo Nardone, Jingjing Zhao, et al.
The Journal of Thoracic and Cardiovascular Surgery|June 26, 2016
Pathway for surgeons and programs to establish and maintain a successful robot-assisted adult cardiac surgery programEvelio Rodriguez, L Wiley Nifong, Johannes Bonatti, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 16, 2014
Δ9-tetrahydrocannabinol and endocannabinoid degradative enzyme inhibitors attenuate intracranial self-stimulation in miceJason M Wiebelhaus, Travis W Grim, Robert A Owens, et al.
Pageof 62